Editor's Picks

Device companies need to understand that the surgeons they serve are on the cusp of significant change.

Orthopedic M&A activity is challenged by the COVID-19 environment. We review earlier announced acquisitions and provide thoughts on future activity.

The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to share how competitors and customers are reacting.

The site addresses your requests to zero in on the market segment and product-specific content you seek fast while using your preferred device.

First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month.

The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19.

After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments.

The “wait and see” period for enabling technology in orthopedics is over. Commentary from executives and spending patterns of the largest orthopedic companies affirmed that message in the first three months of 2020.